Skip to content
ClinCalc Pro
Menu
Heparin Reversal Agent

Protamine Sulphate

Brand names: Prosulf

Protamine sulphate is a heparin antagonist used to reverse the anticoagulant effect of unfractionated heparin, most commonly after cardiopulmonary bypass.

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: Guided by the amount of heparin to be neutralised — each mg of protamine sulfate neutralises not less than 100 USP Heparin Units
Route: Very slow intravenous injection
Frequency: over a 10-minute period
Max: 50 mg (dose must not exceed 50 mg)
Because heparin disappears rapidly from the circulation, the required protamine dose decreases rapidly with time elapsed after the heparin injection — e.g. if given 30 minutes after heparin, one-half the usual dose may be sufficient. Dosage should be guided by blood coagulation studies. Intended for injection without further dilution (D5-W or normal saline may be used if dilution is desired; do not store diluted solutions — no preservative). Do not mix with other drugs without knowledge of compatibility (incompatible with certain antibiotics including several cephalosporins and penicillins). Source is US labelling (Fresenius Kabi) — no UK SPC was fetched; verify against UK SPC.

Dose auto-extracted from US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

Contraindications

  • Patients who have shown previous intolerance to the drug

Side effects

  • Sudden fall in blood pressure (hypotension)
  • Bradycardia
  • Transitory flushing and feeling of warmth; dyspnoea
  • Nausea, vomiting and lassitude; back pain (in conscious patients)
  • Severe anaphylaxis / anaphylactoid reactions with circulatory collapse, capillary leak and noncardiogenic pulmonary oedema (may be fatal)

Interactions

  • Incompatible with certain antibiotics including several cephalosporins and penicillins — do not mix without knowledge of compatibility

Clinical monograph

How it works

Being strongly basic, it binds the acidic heparin molecule to form a stable inactive complex, neutralising heparin's anticoagulant activity.

Prescribing in practice

  • It can cause severe hypotension, bradycardia and anaphylactoid reactions, especially with rapid administration, so it must be given slowly with resuscitation facilities available.
  • Given in excess or without circulating heparin it has an intrinsic anticoagulant effect, and it only partially reverses low-molecular-weight heparins.
  • Risk of serious reactions is increased in patients previously exposed to protamine-containing insulins, those with fish allergy and men who have had a vasectomy.

Monitoring

Monitor blood pressure, heart rate and clotting status, using anticoagulation assays such as activated clotting time to guide and confirm reversal.

Counselling the patient

  • Given slowly by trained staff with close cardiovascular monitoring.
  • Flag any history of fish allergy, previous protamine reactions or protamine-containing insulin use before administration.

Evidence & guidelines

Its use for heparin reversal after cardiac surgery is standard practice supported by the SPC and cardiothoracic anaesthesia guidance.

Reference: AAGBI Guidelines; Society of Thoracic Surgeons Guidelines on Anticoagulation; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.